Trifluoroacetic acid → HCID 86721881, compound
Reaction equation
C(OC([N:8]1[CH2:13][CH2:12][C@@H:11]([O:14][C:15]2[CH:20]=[CH:19][C:18]([S:21](=[O:36])(=[O:35])[N:22]([CH2:27][C:28]3[CH:33]=[CH:32][C:31]([Cl:34])=[CH:30][CH:29]=3)[CH2:23][CH:24]([CH3:26])[CH3:25])=[CH:17][CH:16]=2)[C@H:10]([OH:37])[CH2:9]1)=O)(C)(C)C.C(O)(C(F)(F)F)=O>C(Cl)Cl>[Cl:34][C:31]1[CH:32]=[CH:33][C:28]([CH2:27][N:22]([CH2:23][CH:24]([CH3:26])[CH3:25])[S:21]([C:18]2[CH:17]=[CH:16][C:15]([O:14][C@@H:11]3[CH2:12][CH2:13][NH:8][CH2:9][C@H:10]3[OH:37])=[CH:20][CH:19]=2)(=[O:36])=[O:35])=[CH:29][CH:30]=1Participants
4
Reactant 2
Product 1
Reagents, catalysts & solvents 1
Procedure
To a solution of (+/−)trans-4-{4-[(4-chloro-benzyl)-isobutyl-sulfamoyl]-phenoxy}-3-hydroxy-piperidine-1-carboxylic acid tert-butyl ester (222 mg, 402 μmol) in DCM (8 mL) was added TFA (2 mL) and the reaction was stirred at room temperature for 30 minutes. The reaction was concentrated and purified by SCX column eluting with 2 M NH3 in MeOH to give N-(4-chloro-benzyl)-4-((+/−)trans-3-hydroxy-piperidin-4-yloxy)-N-isobutyl-benzenesulfonamide (202 mg, 447 μmol). LCMS (m/z, Method A) ES+ 453 [M+1]+.
Workup
- concentrationThe reaction was concentrated
- custompurified by SCX column
- washeluting with 2 M NH3 in MeOH
Sources & evidence
- ORD record
- ord-854d0a499f1645db9493055a1d181422
- Source dataset
- uspto-grants-2016_07
- Patent number
- US09382222B2
Reaction notes
Loading…